Interaction of clozapine with the histamine H3 receptor in rat brain. 1995

A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York, N.Y. 10029, USA.

We examined possible interactions between neuroleptics and the histamine H3 receptor and found an interaction of clozapine with this receptor. In competition binding experiments, using the H3 antagonist, [125I]-iodophenpropit, we observed a Ki of 236 +/- 87 nM. Functionally, clozapine was studied on the H3-mediated inhibition of [3H]-5-hydroxytryptamine ([3H]-5-HT) release from rat brain cortex slices. Clozapine acts as an antagonist with an apparent KB value of 79.5 nM.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007550 Isothiuronium An undecenyl THIOUREA which may have topical anti-inflammatory activity. AHR-1911,Isothiouronium,AHR 1911,AHR1911
D008761 Methylhistamines Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors.
D010880 Piperidines A family of hexahydropyridines.
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
January 1996, Archiv der Pharmazie,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
May 1988, Naunyn-Schmiedeberg's archives of pharmacology,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
March 2002, Journal of neural transmission (Vienna, Austria : 1996),
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
July 1966, The Journal of pharmacology and experimental therapeutics,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
November 1988, European journal of pharmacology,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
June 1991, Biochemical and biophysical research communications,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
January 2000, Journal of neurochemistry,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
September 1978, European journal of pharmacology,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
March 1998, Brain research,
A A Rodrigues, and F P Jansen, and R Leurs, and H Timmerman, and G D Prell
November 1990, Journal of neurochemistry,
Copied contents to your clipboard!